Mo1890 VEDOLIZUMAB DOSE ESCALATION IMPROVES DISEASE ACTIVITY FOR “PARTIAL RESPONDERS” IN ULCERATIVE COLITIS
Gastroenterology(2020)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined